1Dowsett M, Daffada A, Chen CM, et al. Oestrogen receptor mutants and variants in breast cancer [J]. Eur J Cancer,1997,33(8) :1177 - 1183.
2Sakamoto A, Oda Y, Yukihide Iwamoto, et al. A Comparative Study of Fibrous Dysplasia and Osteofibrous Dysplasia with Regard to GS Mutation at the Arg201 Codon[J]. J Mol Diagn ,2000 2 : 67 - 72.
3Castano E,Vorojeikina DP,Notides AC. Phosphorylation of serine- 167 on the human oestrogen receptor is important for oestrogen response element binding and transcriptional activation [J]. Biochem J, 1997,326 ( Pt 1 ) : 149 - 157.
4Henttu PM, Kalkhoven E, Parker MG. AF - 2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclearreceptors [ J ]. Mol Cell Biol, 1997,17 (4) : 1832 - 1839.
5Ekena K,Weis KE,Katzenellenbogen JA. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens[J]. J Biol Chem,1997,272(8) :5069 -5075.
6Pink JJ, Fritsch M, Bilimoria MM, et al. Cloning and characterization of a 77 - kDa oestrogen receptor isolated from a human breast cancer cell line [J]. Br J Cancer,1997,75 ( 1 ) : 17 - 27.
7Arnold SF, Melamed M , Vorojeikina DP, et al. Estradiol -binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation[ J ]. Mol Endocrinol, 1997,11 ( 1 ) :48 - 53.
8Weis KE, Ekena K,Thomas JA,et al. Constitutively acting human estrogen receptors containing amino acid substitution for tyrosine 537 in the receptor protein [ J ]. Molec Endocr,1996,10 : 1388 - 1398.
9Teilmann G, Juul A, Skakkebaek NE, Toppari J. Putative effects of endocrine disrupters on pubertal development in the human [J]. Best Pract Res Clin Endocrinol Metab,2002,16(1) : 105 -121.
10Zhang QX, Borg A, Wolf DM,et al. An estrogen receptor mutant with strong hormone - independent activity from a metastatic breast cancer [J]. Cancer Res, 1997,57 ( 7 ) :1244 - 1249.
